Solventum Corp (SOLV) stock

SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3092% above fair value

$88.81+0.19 (+0.21%)

Close on Nov 12, 2026Market cap $15.12BP/E 99.8Yield –

Solventum statistics

94 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 25, 2027 (estimated, during market hours)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $15.12B; $501.02M
Enterprise Value: $19.73B; $422.54M
PE Ratio: 99.79; 29.97
PS Ratio: 1.85; 3.04
PB Ratio: 3.15; 3.29
P/OCF Ratio: 48.77; 22.12

Enterprise valuationIndustry

EV / Sales: 2.42; 2.70
EV / EBITDA: 20.24; 18.53
EV / EBIT: 43.47; 24.04

Share statisticsIndustry

Shares Outstanding: 170M; 43M
Shares Change (YoY): -0.64%; 3.22%
Shares Change (QoQ): -0.09%; 0.16%
Float: 119M; 37M
Shares Held by Insiders: 30.3%; 10.5%
Shares Held by Institutions: 75.0%; 60.2%

Short sellingIndustry

Short Interest: 5M; –
Short Interest Change: 1.93%; -2.57%
Short % of Float: 4.26%; 5.12%
Short % of Shares Outstanding: 2.97%; 3.98%
Days to Cover: 4.60; 3.94

Stock price statisticsIndustry

52-Week High: $94.16; –
52-Week Low: $62.38; –
20-Day Moving Average: $86.33; –
50-Day Moving Average: $87.58; –
200-Day Moving Average: $78.78; –
Average True Range (14): $2.89; –
Price Change (1 Week): 1.87%; 2.01%
Price Change (1 Month): 1.78%; -0.57%
Price Change (3 Months): 0.25%; -7.91%
Price Change (6 Months): 19.3%; -0.90%
Price Change (YTD): 12.1%; -0.82%
Price Change (1 Year): 20.2%; -1.18%
Average Volume (10 Days): 1M; –
Average Volume (20 Days): 1M; –
Average Volume (90 Days): 1M; –
Relative Volume: 0.93; 0.82
Relative Strength Index (14): 54.7; 47.7
Volatility (1 Year): 29.9%; 64.2%
Beta (5 Years): 0.53; 1.05

MarginsIndustry

Gross Margin: 54.8%; 55.9%
Operating Margin: 5.56%; -5.17%
Pretax Margin: 2.09%; -2.55%
Profit Margin: 1.91%; -9.23%
EBITDA Margin: 11.9%; -2.82%
FCF Margin: 0.00%; 0.40%

Returns on capitalIndustry

Return on Equity (ROE): 3.19%; -17.1%
Return on Assets (ROA): 1.11%; -12.2%
Return on Invested Capital (ROIC): 4.66%; -3.22%
Return on Capital Employed (ROCE): 4.29%; -8.13%

Financial positionIndustry

Current Ratio: 1.03; 2.45
Quick Ratio: 0.51; 1.53
Debt / Equity: 1.05; 0.42
Debt / EBITDA: 5.20; 2.19
Net Debt / EBITDA: 4.74; 1.53

GrowthIndustry

Revenue Growth (YoY): -2.84%; 9.24%
Net Income Growth (YoY): -89.8%; 13.4%
EPS Growth (YoY): -89.8%; 15.1%
FCF Growth (YoY): -100.0%; 7.64%
Revenue Growth (3Y CAGR): 0.79%; 7.08%
EPS Growth (3Y CAGR): 4.51%; 3.11%

EfficiencyIndustry

Asset Turnover: 0.58; 0.59
Inventory Turnover: 3.43; 2.20
Revenue Per Employee: $816.30K; $330.60K
Profits Per Employee: $15.60K; -$41.39K
Employee Count: 10,000; 186
WACC: 7.21%; 9.71%

Income statement (TTM)Industry

Revenue: $8.16B; $106.81M
Gross Profit: $4.47B; $62.29M
Operating Income: $454.00M; -$4.10M
Pretax Income: $171.00M; -$1.69M
Net Income: $156.00M; -$6.19M
EBITDA: $975.00M; -$1.98M
EPS (Diluted): $0.89; -$0.08

Balance sheetIndustry

Cash & Short-Term Investments: $451.00M; $38.08M
Total Debt: $5.07B; $96.00M
Net Cash (Debt): -$4.62B; $3.73M
Net Cash Per Share: -$27.12; $0.24
Equity (Book Value): $4.81B; $63.44M
Book Value Per Share: $28.23; $3.26
Tangible Book Value: -$3.13B; $11.04M
Working Capital: $117.00M; $56.85M

Cash flow (TTM)Industry

Operating Cash Flow: $310.00M; -$541.49K
Capital Expenditures: -$310.00M; -$3.69M
Free Cash Flow: $0; -$387.37K
FCF Per Share: $0.00; -$0.01

Dividends and yieldsIndustry

Earnings Yield: 1.03%; -4.70%
FCF Yield: 0.00%; 0.24%

Taxes and interestIndustry

Income Tax: $14.00M; $1.63M
Effective Tax Rate: 8.19%; 18.3%

Scores and fair valueIndustry

Graham Number: $23.78; $38.11
Graham Upside: -73.2%; -56.3%
Altman Z-Score: 1.85; 2.44
Piotroski F-Score: 5; 5
Beneish M-Score: -2.05; -2.64

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	SOLV	S&P 500	Difference
1 month	+4.1%	-2.7%	+6.8 pts
3 months	+4.1%	-1.7%	+5.9 pts
Year to date	+12.1%	+11.9%	+0.2 pts
1 year	+20.3%	+12.0%	+8.3 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

5M SOLV shares were sold short on Oct 30, 2026, up 1.9% from the previous report, or 4.26% of the shares available to trade. At recent volumes it would take 4.6 days to buy them back. Over the last 20 sessions, 50.0% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	5,047,939	+1.9%	1,097,821	4.6
Oct 15, 2026	4,952,208	+1.2%	1,051,987	4.7
Sep 30, 2026	4,894,684	+0.7%	901,213	5.4
Sep 15, 2026	4,862,491	+13.1%	857,486	5.7
Aug 31, 2026	4,299,252	+23.8%	985,245	4.4
Aug 14, 2026	3,471,526	-1.2%	1,379,834	2.5
Jul 31, 2026	3,512,330	-18.3%	1,163,085	3.0
Jul 15, 2026	4,297,389	-14.5%	947,646	4.5
Jun 30, 2026	5,023,381	-7.8%	1,616,259	3.1
Jun 15, 2026	5,445,902	-28.2%	1,808,165	3.0
May 29, 2026	7,582,360	-3.9%	2,813,821	2.7
May 15, 2026	7,893,674	+21.7%	1,922,896	4.1